Edition:
United Kingdom

Orexigen Therapeutics unit, ROVI announce agreement


Monday, 1 Aug 2016 

Orexigen Therapeutics Inc : "Expect mysimba to contribute to group's revenue in next few years" . Unit, Laboratorios Farmacéuticos Rovi S.A. executed commercialization and distributorship agreement for mysimba .Rovi expects to begin marketing mysimba by year-end 2016.